Elation Health acquires Aster to expand agentic AI capabilities in United States primary care sector

The acquisition aims to accelerate the creation of the first agentic operating system for primary care, integrating autonomous voice software to handle administrative tasks directly for doctors.

Image source: elationhealth.com
WT default author logo
Women's Tabloid News Desk

The United States clinical technology firm Elation Health has announced its acquisition of Aster, an artificial intelligence-native electronic health record platform that specialises in women’s health. The transaction brings specialised expertise in autonomous artificial intelligence agents to the San Francisco-based company. This integration aims to speed up the development of a dedicated primary care operating system designed to execute administrative work on behalf of medical practitioners rather than simply offering software assistance.

The buyout represents the second major corporate acquisition for Elation Health, following its purchase of Lightning MD in 2023. Aster’s complete operational team will integrate into the corporate structure of the purchasing firm. This includes the chief technology officer, Nacho Vazquez, who architected the full-stack technology of the startup, alongside the sibling co-founders Fifi Kara and Dr Lailah Kara-Newton.

“The Aster team impressed us with their vision and creative inventions to support independent practices,” said Kyna Fong, co-founder and CEO of Elation Health. “Like Elation, Aster was founded by siblings with a personal mission to fix healthcare. That shared north star means they understand what we’re building and why it matters. It was clear right away they would significantly add to our capabilities.”

The incoming startup team brings distinct international and corporate backgrounds to the American healthcare technology company. Fifi Kara is a two-time company founder, an alumnus of the Y Combinator startup accelerator and a former design lead for the health and fitness division of Meta. Dr Lailah Kara-Newton holds an MBBS medical degree from Barts and The London School of Medicine and spent more than seven years practicing medicine with a focus on obstetrics and gynaecology, having previously published clinical research with the World Health Organization and the Royal College of Obstetricians and Gynaecologists.

“We’re joining forces with Elation Health at a moment of extraordinary change and opportunity in healthcare,” said Fifi Kara. “From the moment we met Kyna Fong, Ashley Rogers, and the Elation leadership team, it was clear we were aligned on what matters most: that clinicians deserve truly incredible software that brings joy back to their practice. Together, we can now bring that vision to millions of primary care patients across the country.”

The foundations of the acquired medical software startup were highly personal. The founding sisters established the business after Dr Kara-Newton experienced undiagnosed preeclampsia during her first pregnancy, resulting in an emergency Caesarean section and a newborn intensive care unit admission for her son. The experience motivated the founders to construct an artificial intelligence-native platform tailored for women’s health providers to help prevent identical outcomes, and that underlying voice agent technology, known as Atlas, will now be absorbed into the wider primary care platform.

Share:

Related Insights

Governor Moore announces Nicole Earle as chair of the Maryland Racing Commission in historic appointment for US racing body

Melinda French Gates pledges $215 million to tackle global gaps in women’s healthcare

Riedel Group appoints Gudrun Scharler as the new CEO of Riedel Networks

OQC, JPMorganChase and AMD launch London quantum computing research hub

Helaina and Nestlé partner to develop new bioactive proteins for infant nutrition

Intention.ly secures official Women’s Business Enterprise certification from WBENC

Joanne McNamara has been appointed as the new CEO of British Land

London-based children’s nutrition brand Lune & Wild secures £2 million in Series A funding round